Abstract
We describe here the definition and characterization of antigen CT-8/HOM-TES-85 encoded by a previously unknown gene and identified by serological expression screening using antibodies from a seminoma patient. Intriguingly, the leucine zipper region of CT-8/HOM-TES-85 shows an atypical amphipathy with clusters of hydrophobic residues that is exclusively shared by the N-myc proto-oncogene. CT-8/HOM-TES-85 gene is tightly silenced in normal tissues except for testis. However, it is frequently activated in human neoplasms of different types including lung cancer, ovarian cancer, melanoma and glioma. Endogenous as well as heterogeneously expressed CT-8/HOM-TES-85 targets predominantly to the nucleus forming a distinctive speckled pattern of nuclear dots arranged in macromolecular structures. By co-localization studies these speckles were identified as loci of transcriptional activity and splicing, suggesting that CT-8/HOM-TES-85 may be involved in these processes. The aberrant expression of CT-8/HOM-TES-85 in human neoplasms might therefore be involved in cancer associated alterations of transcriptional or post-transcriptional processes and thus may disclose new mechanisms involved in the manifestation of the cancer phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrade LE, Chan EK, Raska I, Peebles CL, Roos G, Tan EM . 1991 J. Exp. Med., 173: 1407–1419
Bergsagel PL, Victor-Kobrin C, Brents LA, Mushinski JF, Kuehl WM . 1992 Curr. Top. Microbiol. Immunol. 182: 223–228
Boel P, Wildmann C, Sensei ML, Brasseur R, Renauld M, Coulie P, Boon T, van der Bruggen P . 1995 Immunity 2: 167–175
Boon T, Old LJ . 1997 Curr. Opin. Immunol. 9: 681–683
Boon T, Coulie PG, Van den Eynde B . 1997 Immunol. Today 18: 267–268
Chan EK, Sullivan KF, Fox RI, Tan EM . 1989 J. Autoimmun. 2: 321–327
Chen YT, Scanlan MJ, Sahin U, Türeci Ö, Güre AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ . 1997 Proc. Natl. Acad. Sci. USA 94: 1914–1918
Chen YT, Old LJ . 1999 Cancer J. Sci. Am. 5: 16–17
Deleage G, Roux B . 1987 Protein Eng. 1: 289–294
De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T . 1996 Proc. Natl. Acad. Sci. USA 93: 7149–7153
De Smet C, Lurquin C, Lethe B, Martelange V, Boon T . 1999 Mol. Cell. Biol. 19: 7327–7335
Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD . 1996 Proc. Natl. Acad. Sci. USA 93: 6025–6030
Disis ML, Cheever MA . 1996 Curr. Opin. Immunol. 8: 637–642
Eichmüller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D . 2001 Proc. Natl. Acad. Sci. USA 98: 629–634
Fu XD, Maniatis T . 1990 Nature 343: 437–441
Garnier J, Gibrat JF, Robson B . 1996 Methods Enzymol. 266: 540–553
Gaugler B, Van den Eynde B, van der Bruggen P, Romero R, Gafario JJ, De Plaen E, Lethe B, Brasseur G, Boon T . 1995 J. Exp. Med. 79: 921–930
Gentz R, Rauscher FJ, Abate C, Curran T . 1989 Science 243: 1695–1699
Geourjon C, Deleage G . 1995 Comput. Appl. Biosci. 11: 681–684
Güre A, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ, Chen YT . 2000 Proc. Natl. Acad. Sci. USA 97: 4198–4203
Halle JP, Meisterernst M . 1996 Trends Genet. 12: 161–163
Kallenberg CG . 1990 Clin. Rheumatol. 9S1: 136–139
Kim J, Noskov VN, Lu X, Bergmann A, Ren X, Warth T, Richardson P, Kouprina N, Stubbs L . 2000 Genome Res. 10: 1138–1147
Kouzarides T, Ziff E . 1988 Nature 336: 646–651
Kramer H, Phistry M . 1996 J. Cell Biol. 133: 1205–1215
Lethe B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, Boon T . 1998 Int. J. Cancer 76: 903–908
Lim FI, Soulez M, Koczan D, Thiesen HJ, Knight JC . 1998 Oncogene 17: 2013–2018
Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P . 1997 J. Exp. Med. 186: 785–793
McCauliffe DP, Lux FA, Lieu TS, Sanz I, Hanke J, Newkirk MM, Siciliano MJ, Sontheimer RD, Capra JD . 1989 J. Autoimmun. 2: 375–381
Meuwissen RJL, Meerts JMN, Hoovers NJ, Leschot T, Heyting C . 1997 Genomics 37: 101–106
Nakai K, Horton P . 1999 Trends Biochem. Sci. 24: 34–36
Neugebauer KM, Roth MB . 1997 Genes Dev. 11: 1148–1159
Ochs RL, Lischwe MA, Spohn WH, Busch H . 1985 Biol. Cell 54: 123–133
Old LJ, Chen YT . 1998 J. Exp. Med. 187: 1163–1167
Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E . 2001 Proc. Natl. Acad. Sci. USA 98: 3282–3287
Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P . 1997 Cancer Res. 57: 462–463
Sahin U, Türeci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Pfreundschuh M . 1995 Proc. Natl. Acad. Sci. USA 92: 11810–11813
Sahin U, Türeci Ö, Pfreundschuh M . 1997 Curr. Opin. Immunol. 9: 709–716
Sahin U, Türeci Ö, Chen YT, Seitz G, Villena C, Old LJ, Pfreundschuh M . 1998 Int. J. Cancer 78: 387–389
Sleeman JE, Lamond AI . 1999 Curr. Opin. Cell. Biol. 11: 372–377
Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ . 1998 J. Exp. Med. 187: 1349–1354
Szostecki C, Krippner H, Penner E, Bautz FA . 1987 Clin. Exp. Immunol. 68: 108–116
Türeci Ö, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M . 1996 Cancer Res. 56: 4766–4772
Türeci Ö, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M . 1998 Proc. Natl. Acad. Sci. USA 95: 5211–5216
Türeci Ö, Sahin U, Pfreundschuh M . 1997 Mol. Med. Today 3: 342–349
Turner R, Tjian R . 1989 Science 243: 1689–1694
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A, Boon T . 1991 Science 254: 1643–1647
Venrooij WJ, Sillikens PT . 1989 Clin. Exp. Rheumatol. 7: 635–645
Wang J, Cao LG, Wang YL, Pederson T . 1991 Proc. Natl. Acad. Sci. USA 88: 7391–7395
Wang RF, Wang X, Atwood AC, Topalian SL, Rosenberg SA . 1999 Science 284: 1351–1354
Wei X, Somanathan S, Samarabandu J, Berezney R . 1999 J. Cell Biol. 146: 543–558
Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde KH, Beach D . 1995 Science 269: 1281–1284
Wynshaw-Boris A, Gambello MJ . 2001 Genes Dev. 15: 639–651
Acknowledgements
We thank Mr Uli Luxemburger, Mrs Evi Regitz and Mr Michael Becker for excellent technical assistance. This work was supported in parts by the Sonderforschungsbereich 399 and 432, by Deutsche Forschungsgemeinschaft (TU 115/1-2 and SA 776/2-1), the BIOMED II program and the 5th FP of the European Commission.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Türeci, Ö., Sahin, U., Koslowski, M. et al. A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 21, 3879–3888 (2002). https://doi.org/10.1038/sj.onc.1205481
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205481
Keywords
This article is cited by
-
Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
Journal of Ovarian Research (2019)
-
IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma
Journal of Investigative Dermatology (2015)
-
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
Cancer Immunology, Immunotherapy (2013)
-
Cancer/testis antigens, gametogenesis and cancer
Nature Reviews Cancer (2005)
-
Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing
BMC Genomics (2004)